Interferon therapy improves the irregular regeneration of hepatocytes in liver in patients with C-viral chronic hepatitis and liver cirrhosis

Intervirology

Volumn 50, Issue 2, 2007, Pages 138-149

  Moriyama, Mitsuhiko ^a   Matsumura, Hiroshi ^a   Oshiro, Shu ^a   Nakamura, Hitomi ^a   Arakawa, Yasuo ^a   Nirei, Kazushige ^a   Aoki, Hiroshi ^a   Yamagami, Hiroaki ^a   Kaneko, Miki ^a   Tanaka, Naohide ^a   Arakawa, Yasuyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; Hepatocellular carcinoma; Interferon; Irregular regeneration of hepatocytes; Irregular regeneration score

Indexed keywords

ALPHA INTERFERON; CANFERON; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER REGENERATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROBABILITY; RISK FACTOR;

ADULT; AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C, CHRONIC; HEPATOCYTES; HISTOCYTOCHEMISTRY; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON-ALPHA; LIVER CIRRHOSIS; LIVER REGENERATION; MALE; MIDDLE AGED; RISK FACTORS;

HEPATITIS C VIRUS;

EID: 33846989298     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098240     Document Type: Article

References (19)

1. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshida K, Kakumu S, Iijima A, Urushihara A, Kiyosawa K, Okuda M, Hino K, Okita K: Risk factor for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology 1998;27:1394-1402.
2. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S: Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-1055.
3. Tanaka K, Sata M, Uchimura Y, Suzuki H, Tanikawa K: Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma? Oncol Rep 1998;5:205-208.
4. Yoshida H, Shiratori Y, Moriyama M, et al: Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy. Ann Intern Med 1999;131:174-181.
5. Matsumura H, Moriyama M, Goto I, Tanaka N, Ohkubo H, Arakawa Y: Natural course of progression of liver fibrosis in patients with chronic liver disease type C in Japan: a study of 527 patients at one establishment. J Viral Hepat 2000;7:268-275.
6. Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
7. Serfaty L, Chazouilleres O, Poujol-Robert A, Morand-Joubert L, Dubois C, Chretien Y, Poupon RE, Petit JC, Poupon R: Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology 1997;26:776-779.
8. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M, Omata M: Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995;22:1027-1033.
9. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, Kuroki T, Nishiguchi S, Sata M, Yamada G, Fujiyama S, Yoshida H, Omata M: Histological improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000;132:517-524.
10. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M: Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995;21:650-655.
11. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, Lefkowitch JH, Ludwig J, Okuda K: The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-1340.
12. Desmet VJ, Gerber M, Hoofnagle J.H, Manns M, Scheuer PJ: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
13. Uchida T: Small hepatocellular carcinoma: its relationship to multistep hepatocarcinogenesis. Pathol Int 1995;45:175-184.
14. Uchida T: Pathology of hepatitis C. Intervirology 1994;37:126-132.
15. Uchida T, Kronborg I, Peters RL: Acute hepatitis: morhpologic and functional correlations in human livers. Hum Pathol 1984;15:267-277.
16. Ueno Y, Moriyama M, Uchida T, Arakawa, Y: Irregular regeneration of hepatocytes is an important factor of hepatocarcinogenesis of liver disease. Hepatology 2001;33:357-362.
17. Shibata M, Morizane T, Uchida T, Yamagami T, Onozuko Y, Nakano M, Mitamura K, Ueno Y: Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet 1998;351:1773-1777.
18. Okamoto H., Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al: Typing of hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-679.
19. Simmonds P, Alberti A, Alter J, et al: A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:1321-1324.